Dr. Christopher Riedl, MD, PhD

Similar providers on Zocdoc

Top-rated

Closest to you

Available today

Dr. Ravindra Kashyap, MD

Internist

Eliezer Gurkov, PA

Physician Assistant

Dr. Tayyab Malik, MD

Family Physician

There are currently no additional providers matching this criteria

Dr. Ravindra Kashyap, MD

Internist

Eliezer Gurkov, PA

Physician Assistant

Dr. Tayyab Malik, MD

Family Physician

In-network insurances

Aetna

BlueCross BlueShield

Cigna

Emblem Health

Medicare

UnitedHealthcare

UnitedHealthcare Oxford

Aetna

BlueCross BlueShield

Cigna

Emblem Health

Popular visit reasons

CT Scan - Abdominal / Pelvic

CT Scan - Whole Body Scan

CT Scan Report - Head

CT Scan Report - Lungs

CT Scan Report - Other

PET / CT Scan Report

PET Scan

Radiology Consultation

CT Scan - Abdominal / Pelvic

CT Scan - Whole Body Scan

CT Scan Report - Head

CT Scan Report - Lungs

More about Dr. Christopher Riedl, MD, PhD

***Please expect a phone call from Dr. Riedl's office to confirm your appointment within 24-48 hours of booking. Dr. Christopher Riedl is a Dual-Board Certified Nuclear Radiologist and former Assistant Professor of Radiology at Memorial Sloan Kettering Cancer Center. He has published over 60 peer-reviewed scientific articles and is considered a top researcher in his field. “I see every patient that sets foot into our practice as a new opportunity for our team to provide the best care possible. After 20 years of refining my diagnostic skills, mostly in the reading rooms of major hospitals, I now take pride in my patient care by directly connecting with my patients and their referring physicians.”

Education & experience

Education

Medical School - Universidad de La Laguna Facultad de Medicina

University of Vienna, Residency in Radiology

University of Vienna (PhD)

Practice

imagingwest

Certifications

American Board of Radiology

American Board of Nuclear Medicine

Professional memberships

Radiological Society of North America

Society of Nuclear Medicine and Molecular Imaging

European Congress of Radiology

Society of Nuclear Medicine and Molecular Imaging

Awards and publications

Vienna Schering Award

Astra Zeneca-Förderungspreis

RSNA Roentgen Resident/Fellow Research Award

Best Scientific Presentations ECR 2007

Bayer Schering Pharma Scholarship

Fuchsjäger MH, Helbich TH, Ringl H, Funovics MA, Rudas M, Riedl CC, Pfarl G. Electrical impedance scanning in the differentiation of suspicious breast lesions: Comparison with mammography, ultrasound and histopathology. RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren. 2002;174(12):1522-1529.

Pfarl G, Helbich TH, Riedl CC, Rudas M, Wagner T, Memarsadeghi M, Lomoschitz F. Stereotactic needle breast biopsy: Diagnostic reliability of various biopsy systems and needle sizes. RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren. 2002;174(5):614-619.

Pfarl G, Helbich TH, Riedl CC, Wagner T, Gnant M, Rudas M, Liberman L. Stereotactic II-gauge vacuum-assisted breast biopsy: A validation study. American Journal of Roentgenology. 2002;179(6):1503-1507.

Riedl CC, Pfarl G, Helbich TH, Memarsadeghi M, Wagner T, Rudas M, Fuchsjäger M. Comparison of wire versus carbon localization of non-palpable breast lesions. RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren. 2002;174(9):1126-1131.

Memarsadeghi M, Pfarl G, Riedl CC, Wagner T, Rudas M, Helbich TH. Value of 14-gauge ultrasound-guided large-core needle biopsy of breast lesions: Own results in comparison with the literature. RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren. 2003;175(3):374-380.

Krestan CR, Klein N, Fleischmann D, Kaneider A, Novotny C, Kreuzer S, Riedl CC, Minar E, Janata K, Herold CJ. Value of negative spiral CT angiography in patients with suspected acute PE: Analysis of PE occurrence and outcome. European Radiology. 2004;14(1):93-98.

Riedl CC, Pfarl G, Memarsadeghi M, Wagner T, Fitzal F, Rudas M, Helbich TH. Lesion miss rates and false-negative rates for 1115 consecutive cases of stereotactically guided needle-localized open breast biopsy with long-term follow-up. Radiology. 2005;237(3):847-853.

Adusumilli PS, Eisenberg DP, Chun YS, Ryu KW, Ben-Porat L, Hendershott KJ, Chan MK, Huq R, Riedl CC, Fong Y. Virally directed fluorescent imaging improves diagnostic sensitivity in the detection of minimal residual disease after potentially curative cytoreductive surgery. Journal of Gastrointestinal Surgery. 2005;9(8):1138-1147.

Floery D, Helbich TH, Riedl CC, Jaromi S, Weber M, Leodolter S, Fuchsjaeger MH. Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): Initial experience. Investigative Radiology. 2005;40(6):328-335.

Fuchsjaeger MH, Flöry D, Reiner CS, Rudas M, Riedl CC, Helbich TH. The negative predictive value of electrical impedance scanning in BI-RADS category IV breast lesions. Investigative Radiology. 2005;40(7):478-485.

Riedl CC, Jaromi S, Floery D, Pfarl G, Fuchsjaeger MH, Helbich TH. Potential of dose reduction after marker placement with full-field digital mammography. Investigative Radiology. 2005;40(6):343-348.

Memarsadeghi M, Riedl CC, Kaneider A, Galid A, Rudas M, Matzek W, Helbich TH. Axillary lymph node metastases in patients with breast carcinomas: Assessment with nonenhanced versus USPIO-enhanced MR imaging. Radiology. 2006;241(2):367-377.

Mullerad M, Eisenberg DP, Akhurst TJ, Adusumilli PS, Riedl CC, Bhargava A, Gonen M, Finn R, Scardino PT, Fong Y. Use of positron emission tomography to target prostate cancer gene therapy by oncolytic herpes simplex virus. Molecular Imaging and Biology. 2006;8(1):30-35.

Brader P, Riedl CC, Woo Y, Ponomarev V, Zanzonico P, Wen B, Cai S, Hricak H, Fong Y, Blasberg R, Serganova I. Imaging of hypoxia-driven gene expression in an orthotopic liver tumor model. Molecular Cancer Therapeutics. 2007;6(11):2900-2908.

Lin SF, Yu Z, Riedl CC, Woo Y, Zhang Q, Yu YA, Timiryasova T, Chen N, Shah JP, Szalay AA, Fong Y, Wong RJ. Treatment of anaplastic thyroid carcinoma in vitro with a mutant vaccinia virus. Surgery. 2007;142(6):976-983.

Riedl CC, Akhurst T, Larson S, Stanziale SF, Tuorto S, Bhargava A, Hricak H, Klimstra D, Fong Y. 18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases. Journal of Nuclear Medicine. 2007;48(5):771-775.

Riedl CC, Ponhold L, Flöry D, Weber M, Kroiss R, Wagner T, Fuchsjäger M, Helbich TH. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clinical Cancer Research. 2007;13(20):6144-6152.

Brader P, Stritzker J, Riedl CC, Zanzonico P, Cai S, Burnazi EM, Ghani ER, Hricak H, Szalay AA, Fong Y, Blasberg R. Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging. Clinical Cancer Research. 2008;14(8):2295-2302.

Kelly KJ, Woo Y, Brader P, Yu Z, Riedl CC, Lin SF, Chen N, Yu YA, Rusch VW, Szalay AA, Fong Y. Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma. Human Gene Therapy. 2008;19(8):774-782.

Riedl CC, Brader P, Zanzonico P, Reid V, Woo Y, Wen B, Ling CC, Hricak H, Fong Y, Humm JL. Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: A comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort. European Journal of Nuclear Medicine and Molecular Imaging. 2008;35(1):39-46.

Riedl CC, Brader P, Zanzonico PB, Yun SC, Woo Y, Singh P, Carlin S, Wen B, Ling CC, Hricak H, Fong Y. Imaging hypoxia in orthotopic rat liver tumors with iodine 124-labeled iodoazomycin galactopyranoside PET. Radiology. 2008;248(2):561-570.

Schueller G, Riedl CC, Mallek R, Eibenberger K, Langenberger H, Kaindl E, Kulinna-Cosentini C, Rudas M, Helbich TH. Image Quality, lesion detection, and diagnostic efficacy in digital mammography: Full-field digital mammography versus computed radiography-based mammography using digital storage phosphor plates. European Journal of Radiology. 2008;67(3):487-496.

Ariaratnam N, Riedl CC, Tickoo S, Russo P, Rademaker J, Zhang J. Renal oncocytosis: Imaging considerations. Abdominal Imaging. 2009;34(2):261-264.

Reiner CS, Helbich TH, Rudas M, Ponhold L, Riedl CC, Kropf N, Fuchsjäger MH. Can galactography-guided stereotactic, 11-gauge, vacuum-assisted breast biopsy of intraductal lesions serve as an alternative to surgical biopsy? European Radiology. 2009;19(12):2878-2885.

Strong VE, Galanis CJ, Riedl CC, Longo VA, Daghighian F, Humm JL, Larson SM, Fong Y. Portable PET probes are a novel tool for intraoperative localization of tumor deposits. Annals of Surgical Innovation and Research. 2009;3.

Akin O, Riedl CC, Ishill NM, Moskowitz CS, Zhang J, Hricak H. Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer. European Radiology. 2010;20(4):995-1002.

Gruber R, Riedl CC, Reisegger M, Pinker K, Sturm E, Semturs F, Helbich TH. Perspectives of the digital mammography platform. Radiologe. 2010;50(11):999-1007.

Reisegger M, Schueller G, Gruber R, Pinker K, Riedl CC, Helbich TH. Imaging of molecular structures of breasts with new sonography techniques. Radiologe. 2010;50(11):1014-1021.

Riedl CC, Ponhold L, Gruber R, Pinker K, Helbich TH. New information on high risk breast screening. Radiologe. 2010;50(11):955-963.

Singer CF, Tea MK, Pristauz G, Hubalek M, Rappaport C, Riedl CC, Helbich T. Of breast and ovarian cancer in high risk patients, particularly in women from HBOC (hereditary breast and ovarian cancer) families. Wiener Klinische Wochenschrift. 2012;124(9-10):334-339.

Gruber R, Jaromi S, Rudas M, Pfarl G, Riedl CC, Flöry D, Graf O, Sickles EA, Helbich TH. Histologic work-up of non-palpable breast lesions classified as probably benign at initial mammography and/or ultrasound (BI-RADS category 3). European Journal of Radiology. 2013;82(3):398-403.

Thorek DLJ, Riedl CC, Grimm J. Clinical cerenkov luminescence imaging of 18F-FDG. Journal of Nuclear Medicine. 2014;55(1):95-98.

Riedl CC, Slobod E, Jochelson M, Morrow M, Goldman DA, Gonen M, Weber WA, Ulaner GA. Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years. Journal of Nuclear Medicine. 2014;55(10):1578-1583.

Hogan MP, Goldman DA, Dashevsky B, Riedl CC, Gönen M, Osborne JR, Jochelson M, Hudis C, Morrow M, Ulaner GA. Comparison of 18F-FDG PET/CT for systemic staging of newly diagnosed invasive lobular carcinoma versus invasive ductal carcinoma. Journal of Nuclear Medicine. 2015;56(11):1674-1680.

Phi XA, Houssami N, Obdeijn IM, Warner E, Sardanelli F, Leach MO, Riedl CC, Trop I, Tilanus-Linthorst MMA, Mandel R, Santoro F, Kwan-Lim G, Helbich TH, De Koning HJ, Van Den Heuvel ER, De Bock GH. Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age =50 years: Evidence from an individual patient data meta-analysis. Journal of Clinical Oncology. 2015;33(4):349-356.

Singer CF, Tea MK, Pristauz G, Hubalek M, Rappaport C, Riedl CC, Helbich TH. Clinical Practice Guideline for the prevention and early detection of breast and ovarian cancer in women from HBOC (hereditary breast and ovarian cancer) families. Wiener Klinische Wochenschrift. 2015;127(23-24):981-986.

Phi XA, Saadatmand S, De Bock GH, Warner E, Sardanelli F, Leach MO, Riedl CC, Trop I, Hooning MJ, Mandel R, Santoro F, Kwan-Lim G, Helbich TH, Tilanus-Linthorst MMA, Van Den Heuvel ER, Houssami N. Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: Individual patient data meta-analysis. British Journal of Cancer. 2016;114(6):631-637.

Pinker K, Riedl CC, Ong L, Jochelson M, Ulaner GA, McArthur H, Dickler M, Gönen M, Weber WA. The impact that number of analyzed metastatic breast cancer lesions has on response assessment by 18F-FDG PET/CT Using PERCIST. Journal of Nuclear Medicine. 2016;57(7):1102-1104.

Ulaner GA, Castillo R, Goldman DA, Wills J, Riedl CC, Pinker-Domenig K, Jochelson MS, Gönen M. 18F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2016;43(11):1937-1944.

Ulaner GA, Riedl CC, Dickler MN, Jhaveri K, Pandit-Taskar N, Weber W. Molecular imaging of biomarkers in breast cancer. Journal of Nuclear Medicine. 2016;57:53S-59S.

Riedl CC, Pinker K, Ulaner GA, et al. Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer. European journal of nuclear medicine and molecular imaging. 2017;44(9):1428-1437.

Phi XA, Houssami N, Hooning MJ, Riedl CC, Leach MO, Sardanelli F, Warner E, Trop I, Saadatmand S, Tilanus-Linthorst MMA, Helbich TH, van den Heuvel ER, de Koning HJ, Obdeijn IM, de Bock GH.Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis. European journal of cancer (Oxford, England : 1990). 2017;85:31-38.

Ulaner GA, Lyashchenko SK, Riedl CC, Ruan S, Zanzonico PB, Lake D, Jhaveri K, Zeglis B, Lewis JS, O'Donoghue JA. First-in-human HER2-targeted imaging using (89)Zr-pertuzumab PET/CT: Dosimetry and clinical application in patients with breast cancer. J Nucl Med. 2018 Jun;59(6):900-906.

Ward J, Ulaner GA, Arelia N, Riedl CC. Adalimumab induced Epstein Barr virus related lymphoproliferative disorder on FDG PET/CT. Clinical Nuclear Medicine. 2018 May;43(5):344-345.

Deipolyi AR, Bromberg JF, Erinjeri JP, Solomon SB, Brody LA, Riedl CC. Abscopal Effect after Radioembolization for Metastatic Breast Cancer in the Setting of Immunotherapy. Journal of Vascular and Interventional Radiology: JVIR. 2018;29(3):432-433.

Ward J, Noy A, Ulaner G, Riedl CC. Adalimumab-Induced Epstein-Barr Virus-Related Lymphoproliferative Disorder on FDG PET/CT. Clinical Nuclear Medicine. 2018;43(5):344-345.

Mahajan S, Goel R, Riedl C, Ulaner GA. Mazabraud's Syndrome Mimicking Metastases on FDG PET/CT in a Patient with Colon Cancer. Clinical Nuclear Medicine. 2018;43(8):625-626.

Marino MA, Riedl CC, Bernathova M, et al. Imaging Phenotypes in Women at High Risk for Breast Cancer on Mammography, Ultrasound, and Magnetic Resonance Imaging Using the Fifth Edition of the Breast Imaging Reporting and Data System. European Journal of Radiology. 2018;106:150-159.

Deipolyi AR, Riedl CC, Bromberg J, Chandarlapaty S, Klebanoff CA, Sofocleous CT, Yarmohammadi H, Brody LA, Boas FE, Ziv E. Association of PI3K Pathway Mutations with Early Positron-Emission Tomography/CT Imaging Response after Radioembolization for Breast Cancer Liver Metastases: Results of a Single-Center Retrospective Pilot Study. J Vasc Interv Radiol. 2018 Sep;29(9):1226-1235.

Ulaner GA, Juarez J, Riedl C, Goldman D. (18)F-FDG PET/CT for systemic staging of newly diagnosed breast cancer in men. J Nucl Med. 2018. 2019 Apr;60(4):472-477.

Mayerhoefer ME, Riedl CC, Kumar A, Gibbs P, Weber M, Tal I, Schilksy J, Schöder H. Radiomic features of glucose metabolism enable prediction of outcome in mantle cell lymphoma. Eur J Nucl Med Mol Imaging. 2019 Jul 8.

Deipolyi AR, England RW, Ridouani F, Riedl CC, Kunin HS, Boas FE, Yarmohammadi H, Sofocleous CT. PET/CT Imaging Characteristics After Radioembolization of Hepatic Metastasis from Breast Cancer. Cardiovasc Intervent Radiol. 2020 Mar;43(3):488-494.

Kirchner J, Riedl CC, Ulaner GA. Patient Repositioning Reveals a Malignant Pleura Effusion Initially Mistaken as a Bone Metastasis on 18FDG PET/CT. Clin Nucl Med. 2019 Dec;44(12):969-970.

Marino MA, Avendano D, Zapata P, Riedl CC, Pinker K. Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools. Oncologist. 2019 Oct 14.

Das JP, Xie L, Riedl CC, Hayes SA, Ginsberg MS, Halpenny DF. Cardiothoracic manifestations of Erdheim-Chester disease. Br J Radiol. 2019Dec;92(1104):20190473.

Ulaner GA, Sobol NB, O'Donoghue JA, Kirov AS, Riedl CC, Min R, Smith E, Carter LM, Lyashchenko SK, Lewis JS, Landgren CO. CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging. Radiology 2020 Apr 7;192621. Online ahead of print.

Mayerhoefer ME, Riedl CC, Kumar A, Dogan A, Gibbs P, Weber M, Staber PB, Castellanos SH, Schöder H. Mayerhoefer ME, Riedl CC, Kumar A, et al. [18F]FDG-PET/CT Radiomics for Prediction of Bone Marrow Involvement in Mantle Cell Lymphoma: A Retrospective Study in 97 Patients. Cancers (Basel). 2020 May 2;12(5):E1138

Deipolyi AR, England RW, Ridouani F, Riedl CC, Kunin HS, Boas FE, Yarmohammadi H, Sofocleous CT. Reply to: "Regarding 'PET/CT Imaging Characteristics After Radioembolization of Hepatic Metastasis from Breast Cancer'". Cardiovasc Intervent Radiol. 2020;43(5):799. doi:10.1007/s00270-020-02428-2

Ulaner GA, Carrasquillo JA, Riedl CC, Yeh R, Hatzoglou V, Ross DS, Jhaveri K, Chandarlapaty S, Hyman DM, Zeglis BM, Lyashchenko SK, Lewis JS. Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab PET/CT. Radiology. 2020;296(2):370-378. doi:10.1148/radiol.2020192828

Das JP, Riedl CC, Ulaner GA. 18F-FDG PET/CT Helps Differentiate Peripheral Nerve Myeloid Sarcoma From a Presumed Benign Nerve Sheath Tumor. Clin Nucl Med. 2020 Dec;45(12):989-991

Young RJ, Demétrio De Souza França P, Pirovano G, Piotrowski AF, Nicklin PJ, Riedl CC, Schwartz J, Bale TA, Donabedian PL, Kossatz S, Burnazi EM, Roberts S, Lyashchenko SK, Miller AM, Moss NS, Fiasconaro M, Zhang Z, Mauguen A, Reiner T, Dunphy MP. Preclinical and first-in-human-brain-cancer applications of [18F]poly (ADP-ribose) polymerase inhibitor PET/MR. Neurooncol Adv. 2020 Sep 15;2(1):vdaa119

Bitencourt A, Rossi Saccarelli C, Morris EA, Flynn J, Zhang Z, Khan A, Gillespie E, Cahlon O, Mueller B, Cuaron JJ, McCormick B, Powell SN, Plitas G, Razavi P, Pinker K, Riedl CC, Sutton EJ, Braunstein LZ. Regional Lymph Node Involvement Among Patients With De Novo Metastatic Breast Cancer. JAMA Netw Open. 2020 Oct 1;3(10):e2018790

Ulaner GA, Jhaveri K, Chandarlapaty S, Hatzoglou V, Riedl CC, Lewis JS, Mauguen A. Head-to-Head Evaluation of 18F-FES and 18F-FDG PET/CT in Metastatic Invasive Lobular Breast Cancer. J Nucl Med. 2021 Mar;62(3):326-331

Background

Languages spoken

English

German

Gender

Male

NPI number

#1861755605

Christopher Riedl does not participate in Zocdoc to offer online booking at this time

Similar providers on Zocdoc

Top-rated

Closest to you

Available today

Dr. Ravindra Kashyap, MD

Internist

Eliezer Gurkov, PA

Physician Assistant

Dr. Tayyab Malik, MD

Family Physician

There are currently no additional providers matching this criteria

Dr. Ravindra Kashyap, MD

Internist

Eliezer Gurkov, PA

Physician Assistant

Dr. Tayyab Malik, MD

Family Physician